 |
|
Spinal Fluid Appearance of
Richard Janeway, MD;
C. Douglas Maynard, MD;
Richard L. Witcofski, PhD;
Louis C. Lax, MD, PhD
Arch Neurol. 1968;19(6):618-622.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
THE radiopharmaceutical, 99m Technetium (99mTc), pertechnetate is widely used as an agent for brain scanning. Due to its nearly ideal  -emission energy (140 kev), short half-life (six hours), and absence of primary particle radiation, relatively large doses can be used so that definition and resolution are quite good with this isotope. At the same time, the radiation dose is reduced when compared to other brain scanning agents. There is relatively little information available explain why certain lesions are associated with abnormal accumulations of radio-activity while others do not show this uptake. To determine whether alterations in permeability might possibly account for some of this variation, we observed the fractional rate at which an intravenously injected dose of 99mTc pertechnetate appeared in the cerebrospinal fluid (CSF) of neurologically normal patients. This report describes our observations.
Materials and Methods
Sterile 99mTc pertechnetate obtained from a molybdenum-Technetium generator
. . . [Full Text PDF of this Article]
Author Affiliations
Winston-Salem, NC; Los Angeles
From the departments of neurology (Dr. Janeway) and radiology (Drs. Maynard and Witcofski), Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC, and the departments of surgery and physiology, UCLA School of Medicine, The Center for the Health Sciences, Los Angeles (Dr. Lax).
Footnotes
Submitted for publication July 19, 1968; accepted Aug 7.
Reprint requests to Department of Neurology, Bowman Gray School of Medicine, Winston-Salem, NC 27103 (Dr. Janeway).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
